Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection

Transplant Proc. 1999 Sep;31(6):2457-8. doi: 10.1016/s0041-1345(99)00416-9.

Authors

R Bárcena¹, M Domínguez-Antonaya, A López-Sanromán, A Martínez-Turnes, J Urman, S del Campo, N Moreno

Affiliation

¹ Hospital Ramón y Cajal, Servicio Gastroenterologia, Madrid, Spain.

PMID: 10500669
DOI: 10.1016/s0041-1345(99)00416-9

No abstract available

MeSH terms

Adult
Aged
Female
Follow-Up Studies
Hepatitis B / complications
Hepatitis B / drug therapy*
Hepatitis B / surgery*
Humans
Lamivudine / therapeutic use*
Liver Cirrhosis / etiology
Liver Cirrhosis / surgery*
Liver Transplantation*
Male
Middle Aged
Postoperative Complications
Recurrence
Reverse Transcriptase Inhibitors / therapeutic use*

Substances

Reverse Transcriptase Inhibitors
Lamivudine